Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05519137 · ClinicalTrials.gov registry record · NA

Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia

A NA study of Alzheimers Disease, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT05519137 is a NA study of Alzheimers Disease that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 14 participants, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05519137, a NA study of Alzheimers Disease, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.

Conditions Studied

Interventions

  • DEVICE Active lighting intervention
  • DEVICE Control lighting intervention

Study Locations (1)

New York

  • Light and Health Research Center - Menands

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2022-01-06
Est. Completion 2023-05-01
Phase NA

What the Registry Record Tells You About NCT05519137

The ClinicalTrials.gov registry entry for NCT05519137 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (100% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 2 interventions - of which Active lighting intervention is the first listed.

NCT05519137 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05519137 about?

NCT05519137 is a clinical study titled "Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia". To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.

What is the current status of trial NCT05519137?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-01-06. Estimated completion is 2023-05-01.

What conditions does trial NCT05519137 study?

This clinical trial studies the following conditions: Alzheimers Disease.

What interventions are being tested in trial NCT05519137?

The interventions under investigation include: Active lighting intervention (DEVICE), Control lighting intervention (DEVICE).

Who is sponsoring clinical trial NCT05519137?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05519137 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimers Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.